Behavioral Economics to Improve Flu Vaccination Using EHR Nudges Replication (NCT06626321) | Clinical Trial Compass
CompletedNot Applicable
Behavioral Economics to Improve Flu Vaccination Using EHR Nudges Replication
United States26,248 participantsStarted 2024-10-21
Plain-language summary
This study will be a 6-month, cluster randomized, pragmatic replication trial to evaluate the effectiveness of personalized nudges to clinicians and patients, relative to a control, to increase flu vaccination rates among older adults in accordance with CDC guidelines. This will include clinician and patient level nudge interventions, with additional, intensified nudge interventions for patients identified as high risk for not receiving a flu vaccine. Among the intervention clinics, patients will receive pre-visit text message reminders about the flu vaccine, and clinicians will receive a default pended order in the visit encounter in the EHR, along with monthly peer comparison feedback about their flu vaccine completion rate. Patients identified as high risk for noncompletion will be individually randomized to receive an additional bidirectional text message nudge or the standard text messaging
Who can participate
Age range50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age ≥ 50 years
✓. A scheduled new or return (non-urgent/sick) primary care appointment at one of the study practices at Lancaster General Health
✓. Have not received their annual flu vaccine during the active intervention period (September- February)
✓. Eligible to receive the flu vaccine
✓. Age ≥ 70 years
✓. Living in a lower income community (lowest quartile, zip-code based)
✓. Did not receive a flu vaccine in the previous calendar year
✓. Self-identifies as Non-Hispanic Black
Exclusion criteria
✕. Have a documented allergy to flu vaccine
✕. Have a flu vaccine exclusion modifier in Health Maintenance
✕
What they're measuring
1
Proportion of Patients Who Receive the Flu Vaccine at the Visit
Timeframe: 4 days from enrollment, at the eligible visit